SKW-3 Cells
CAD$545.10*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The SKW-3 cell line, originally believed to be derived from the peripheral blood of a 61-year-old male diagnosed with chronic lymphocytic leukemia (CLL), represents a significant point of interest in cancer research, particularly in the study of B-cell leukemias. Over time, critical reassessments using Short Tandem Repeat (STR) profiling have illuminated an important issue-SKW-3 cells are not a pure line from the CLL patient, but are instead contaminated, now identified as a derivative of the KE-37 cell line. This revelation has profound implications for past research and future studies, emphasizing the need for rigorous cell line authentication to ensure experimental accuracy. KE-37, the true origin of the SKW-3 cells, is a B-cell line established from a patient with acute lymphoblastic leukemia (ALL). This shift in origin from CLL to ALL, due to the contamination, drastically alters the biological context and utility of the SKW-3 line. For researchers, this means that any findings or data previously attributed to CLL-specific mechanisms when using SKW-3 must be critically evaluated and potentially revised. The reclassification to a derivative of KE-37 necessitates a shift in the application of SKW-3 cells towards studies more relevant to ALL and its underlying mechanisms, rather than CLL. |
|---|---|
| Organism | Human |
| Tissue | Hematopoietic |
| Disease | T cell leukemia (CLL) |
| Synonyms | SKW3 |
Characteristics
| Age | 27 years |
|---|---|
| Gender | Male |
| Ethnicity | Caucasian |
| Morphology | Round cells |
| Cell type | T Lymphocyte |
| Growth properties | Suspension |
Regulatory Data
| Citation | SKW-3 (Cytion catalog number 300343) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_2197 |
Biomolecular Data
| Antigen expression | CD2+, CD3-, CD4+, CD8, Thy-1-like antigen |
|---|---|
| Products | LECT2 (chemotactic protein) |
Handling
| Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 10% heat-inactivated FBS |
| Doubling time | 30 hours |
| Subculturing | Maintain cultures by periodically adding or replacing the medium. Initiate cultures with a density of 5 x 105 cells/ml and keep the cell concentration within the range of 3 x 105 to 1 x 106 cells/ml for optimal growth. |
| Post-Thaw Recovery | 1 x 105/ml |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 300343-040425 | Certificate of Analysis | 23. May. 2025 | 300343 |
| 300343-516SF | Certificate of Analysis | 23. May. 2025 | 300343 |